New treatment modalities needed to reduce symptoms and long term complications

Ulcerative colitis and Crohn’s disease, the two main forms of inflammatory bowel disease (IBD), are both chronic relapsing diseases characterized by the inflammation of parts of the gastrointestinal tract.

Only in North America, more than 3 millions of poeple are suffering from this debilitating condition. Currently available medications alleviate inflammation but still do not prevent long term complications.